Placebo for Bepirovirsen Solution for Injection, 150 mg/mL SSD
219231
Phase 2 small_molecule active
Quick answer
Placebo for Bepirovirsen Solution for Injection, 150 mg/mL SSD for Hepatitis B is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Hepatitis B
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active